This milestone marks significant progress in the first-in-human evaluation of AAVantgarde's dual-AAV gene therapy designed to address the underlying cause of vision loss in patients with USH1BLONDON a ...
Orphan Drug Designation applies to approximately 50,000 Patients who predominantly suffer from severe chronic pain due to hereditary neuronal sodium ion channel mutationsAdolore's Kv7 voltage-gated po ...
Following The Film Stage’s collective top 50 films of 2025, as part of our year-end coverage, our contributors are sharing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback